ContraFect Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 2077.3%.

Top 25 shareholders own 5.55% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
4.44%	Armistice Capital LLC	475,000	US$30.0k	752%	no data
0.22%	Geode Capital Management, LLC	23,547	US$1.5k	471%	no data
0.22%	Virtu Financial LLC, Asset Management Arm	23,469	US$1.5k	0%	no data
0.2%	Two Sigma Securities, LLC, Asset Management Arm	21,047	US$1.3k	59.7%	no data
0.16%	Acadian Asset Management LLC	17,608	US$1.1k	-18.6%	no data
0.15%	The Vanguard Group, Inc.	16,304	US$1.0k	0%	no data
0.095%	Tower Research Capital LLC	10,182	US$643.1	43.8%	no data
0.05%	BlackRock, Inc.	5,329	US$336.6	-0.71%	no data
0.0095%	Sol Barer	1,019	US$64.4	0%	no data
0.0043%	David Low	463	US$29.3	0%	no data
0.0025%	Royal Bank of Canada, Banking & Securities Investments	271	US$17.1	47.3%	no data
0.0011%	Morgan Stanley, Investment Banking and Brokerage Investments	119	US$7.5	0%	no data
0.00072%	Cary Sucoff	77	US$4.9	0%	no data
0.00058%	JPMorgan Chase & Co, Brokerage and Securities Investments	62	US$3.9	0%	no data
0.00025%	Wells Fargo & Company, Private Banking and Investment Banking Arm	27	US$1.7	145%	no data
0.00024%	Steven Gilman	26	US$1.6	0%	no data
0.00021%	Michael Messinger	23	US$1.4	0%	no data
0.00013%	Central Bank & Trust Company, Asset Management Arm	14	US$0.9	0%	no data
0.00009%	Michael Otto	10	US$0.6	0%	no data
0.00006%	Merrill Lynch & Co. Inc., Banking Investments	6	US$0.4	0%	no data
0.00005%	Washington Trust Advisors, Inc.	5	US$0.3	0%	no data
0.00001%	Roger Pomerantz	1	US$0.07	0%	no data
0.00001%	UBS Asset Management AG	1	US$0.07	-100%	no data
0.00001%	Strategic Advisers LLC	1	US$0.07	0%	no data
0.00001%	Group One Trading LP, Asset Management Arm	1	US$0.07	-99.6%	no data